Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04878211
Status:
TERMINATED
Last Update Posted:
2024-06-20
First Post:
2021-05-03
Brief Title:
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Sponsor:
Organization:
Novartis